NIRS-IVUS for Differentiating Coronary Plaque Rupture, Erosion, and Calcified Nodule in Acute Myocardial Infarction.

calcified nodule intravascular ultrasound near-infrared spectroscopy optical coherence tomography plaque erosion plaque rupture

Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
07 2021
Historique:
received: 17 03 2020
revised: 27 07 2020
accepted: 06 08 2020
pubmed: 23 11 2020
medline: 9 10 2021
entrez: 22 11 2020
Statut: ppublish

Résumé

This study sought to investigate the ability of combined near-infrared spectroscopy and intravascular ultrasound (NIRS-IVUS) to differentiate plaque rupture (PR), plaque erosion (PE), or calcified nodule (CN) in acute myocardial infarction (AMI). Most acute coronary syndromes occur from coronary thrombosis based on PR, PE, or CN. In vivo differentiation among PR, PE, and CN is a major challenge for intravascular imaging. The study enrolled 244 patients with AMI who had a de novo culprit lesion in a native coronary artery. The culprit lesions were assessed by both NIRS-IVUS and optical coherence tomography (OCT). Maximum lipid core burden index in 4 mm (maxLCBI In the development cohort, IVUS-detected plaque cavity showed a high specificity (100%) and intermediate sensitivity (62%) for identifying OCT-PR. IVUS-detected convex calcium showed a high sensitivity (93%) and specificity (100%) for identifying OCT-CN. NIRS-measured maxLCBI By evaluating plaque cavity, convex calcium, and maxLCBI

Sections du résumé

OBJECTIVES
This study sought to investigate the ability of combined near-infrared spectroscopy and intravascular ultrasound (NIRS-IVUS) to differentiate plaque rupture (PR), plaque erosion (PE), or calcified nodule (CN) in acute myocardial infarction (AMI).
BACKGROUND
Most acute coronary syndromes occur from coronary thrombosis based on PR, PE, or CN. In vivo differentiation among PR, PE, and CN is a major challenge for intravascular imaging.
METHODS
The study enrolled 244 patients with AMI who had a de novo culprit lesion in a native coronary artery. The culprit lesions were assessed by both NIRS-IVUS and optical coherence tomography (OCT). Maximum lipid core burden index in 4 mm (maxLCBI
RESULTS
In the development cohort, IVUS-detected plaque cavity showed a high specificity (100%) and intermediate sensitivity (62%) for identifying OCT-PR. IVUS-detected convex calcium showed a high sensitivity (93%) and specificity (100%) for identifying OCT-CN. NIRS-measured maxLCBI
CONCLUSIONS
By evaluating plaque cavity, convex calcium, and maxLCBI

Identifiants

pubmed: 33221211
pii: S1936-878X(20)30827-5
doi: 10.1016/j.jcmg.2020.08.030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1440-1450

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support And Author Disclosures Dr. Madder has received speaker honoraria and research support from Infraredx; and has served on the advisory board of SpectraWave. Dr. Akasaka has received lecture fees from Abbott Vascular, Terumo, and Nipro; and has received research grants from Abbott Vascular, Terumo, and Nipro. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Kosei Terada (K)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takashi Kubo (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: takakubo@wakayama-med.ac.jp.

Takeyoshi Kameyama (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yoshiki Matsuo (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yasushi Ino (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Hiroki Emori (H)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Daisuke Higashioka (D)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yosuke Katayama (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Amir Kh M Khalifa (AKM)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Masahiro Takahata (M)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Kunihiro Shimamura (K)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yasutsugu Shiono (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Atsushi Tanaka (A)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takeshi Hozumi (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Ryan D Madder (RD)

Frederik Meijer Heart & Vascular Institute, Spectrum Health, Grand Rapids, Michigan, USA.

Takashi Akasaka (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH